Nothing Special   »   [go: up one dir, main page]

HRP20190484T1 - Pripravci stanične kulture i postupci proizvodnje polipeptida - Google Patents

Pripravci stanične kulture i postupci proizvodnje polipeptida

Info

Publication number
HRP20190484T1
HRP20190484T1 HRP20190484TT HRP20190484T HRP20190484T1 HR P20190484 T1 HRP20190484 T1 HR P20190484T1 HR P20190484T T HRP20190484T T HR P20190484TT HR P20190484 T HRP20190484 T HR P20190484T HR P20190484 T1 HRP20190484 T1 HR P20190484T1
Authority
HR
Croatia
Prior art keywords
methods
cell culture
polypeptide production
culture compositions
compositions
Prior art date
Application number
HRP20190484TT
Other languages
English (en)
Inventor
Steven J. Meier
Melissa S. Mun
Natarajan VIJAYASANKARAN
Sharat VARMA
Yi Yang
Boyan Zhang
Silvana R. Arevalo
Martin Gawlitzek
Veronica CARVALHAL
Original Assignee
F. Hoffmann - La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49380652&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20190484(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F. Hoffmann - La Roche Ag filed Critical F. Hoffmann - La Roche Ag
Publication of HRP20190484T1 publication Critical patent/HRP20190484T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HRP20190484TT 2012-04-24 2019-03-11 Pripravci stanične kulture i postupci proizvodnje polipeptida HRP20190484T1 (hr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261637780P 2012-04-24 2012-04-24
US201261637778P 2012-04-24 2012-04-24
US13/841,864 US20130281355A1 (en) 2012-04-24 2013-03-15 Cell culture compositions and methods for polypeptide production
EP13720203.2A EP2841561B1 (en) 2012-04-24 2013-04-24 Cell culture compositions and methods for polypeptide production
PCT/US2013/037992 WO2013163294A1 (en) 2012-04-24 2013-04-24 Cell culture compositions and methods for polypeptide production

Publications (1)

Publication Number Publication Date
HRP20190484T1 true HRP20190484T1 (hr) 2019-05-17

Family

ID=49380652

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20190484TT HRP20190484T1 (hr) 2012-04-24 2019-03-11 Pripravci stanične kulture i postupci proizvodnje polipeptida

Country Status (22)

Country Link
US (2) US20130281355A1 (hr)
EP (2) EP2841561B1 (hr)
JP (4) JP6367792B2 (hr)
KR (2) KR102339106B1 (hr)
CN (2) CN111440758A (hr)
AR (1) AR090822A1 (hr)
AU (2) AU2013251647B2 (hr)
BR (1) BR112014026308A8 (hr)
CA (1) CA2871006C (hr)
ES (1) ES2716301T3 (hr)
HK (1) HK1208496A1 (hr)
HR (1) HRP20190484T1 (hr)
IL (1) IL235235A0 (hr)
MX (2) MX363493B (hr)
MY (1) MY181513A (hr)
NZ (1) NZ701791A (hr)
PL (1) PL2841561T3 (hr)
RU (2) RU2018146497A (hr)
SG (2) SG10201810830UA (hr)
SI (1) SI2841561T1 (hr)
WO (1) WO2013163294A1 (hr)
ZA (2) ZA201408092B (hr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
EP2968544A4 (en) * 2013-03-15 2016-10-12 Hoffmann La Roche CELL CULTURE MEDIA AND METHOD FOR PRODUCING ANTIBODY
RU2718986C2 (ru) 2013-03-15 2020-04-15 Дженентек, Инк. Композиции клеточных культур с антиоксидантами и способы получения полипептидов
WO2015051293A2 (en) * 2013-10-04 2015-04-09 Abbvie, Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
CN110945593A (zh) * 2017-06-16 2020-03-31 通用电气健康护理生物科学股份公司 用于预测生物反应器中的过程的产出和对生物反应器中的过程建模的方法
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods
CN111500662A (zh) * 2018-06-25 2020-08-07 深圳市菲鹏生物制药股份有限公司 调节cho-k1表达系统所分泌抗体的酸性峰含量的方法
WO2021087232A1 (en) * 2019-10-31 2021-05-06 William Marsh Rice University Engineered cells for controlled production
IL296864B2 (en) 2019-12-06 2023-10-01 Regeneron Pharma Anti-VEGF protein preparations and methods for their production
JPWO2021153723A1 (hr) * 2020-01-31 2021-08-05
JP7404929B2 (ja) 2020-02-26 2023-12-26 富士フイルムビジネスイノベーション株式会社 発光装置、光学装置及び計測装置
JP7404930B2 (ja) 2020-02-26 2023-12-26 富士フイルムビジネスイノベーション株式会社 発光装置、光学装置及び計測装置
US12103960B2 (en) 2020-05-08 2024-10-01 Regeneron Pharmaceuticals, Inc. VEGF traps and mini-traps and methods for treating ocular disorders and cancer
GB202012991D0 (en) 2020-08-20 2020-10-07 Ucb Biopharma Sprl Cell culture processes
CA3205650A1 (en) * 2020-12-22 2022-06-30 Novartis Ag Methods for reducing the oxidation level of cysteine residues in a secreted recombinantly-expressed protein during cell culture
GB202105424D0 (en) 2021-04-16 2021-06-02 UCB Biopharma SRL Cell culture processes
JP2024535718A (ja) 2021-09-02 2024-10-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 将来の色値又は対応する特性を決定する方法及びその装置
KR102682066B1 (ko) * 2021-10-12 2024-07-05 프레스티지바이오로직스 주식회사 항체 집단의 제조 방법

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
JPS5863385A (ja) 1981-10-02 1983-04-15 ハナ・バイオロジツクス・インコ−ポレ−テツド 免疫系由来の細胞用培地
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4816401A (en) 1985-09-09 1989-03-28 University Of Rochester Serum free cell culture medium
US5091178A (en) 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
US6048728A (en) 1988-09-23 2000-04-11 Chiron Corporation Cell culture medium for enhanced cell growth, culture longevity, and product expression
DE68925971T2 (de) 1988-09-23 1996-09-05 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
JPH03180176A (ja) * 1989-11-16 1991-08-06 W R Grace & Co 細胞培養のための基礎栄養培地
EP0502036B1 (en) 1989-11-22 1995-12-20 Genentech, Inc. Latency associated peptide and uses therefor
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
DK1136556T3 (da) 1991-11-25 2005-10-03 Enzon Inc Fremgangsmåde til fremstilling af multivalente antigen-bindende proteiner
JPH07102147B2 (ja) * 1992-03-16 1995-11-08 株式会社ミドリ十字 ヒト血清アルブミンの着色抑制方法
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US5512477A (en) 1994-04-21 1996-04-30 Genzyme Corporation Serum-free medium supplement
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
DK0802257T3 (da) * 1996-04-19 2002-10-28 Nestle Sa Udødeliggjort cellelinie fra epitelceller i human colon
EP1983044B1 (en) * 1996-10-10 2016-08-10 Life Technologies Corporation Animal cell culture media comprising plant-derived nutrients
US20020012991A1 (en) 1997-04-07 2002-01-31 Florence Chua Nee Ho Kit Fong Cell culture media for enhanced protein production
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
US6160099A (en) * 1998-11-24 2000-12-12 Jonak; Zdenka Ludmila Anti-human αv β3 and αv β5 antibodies
US20060286668A1 (en) 1999-04-30 2006-12-21 Invitrogen Corporation Animal-cell culture media comprising non-animal or plant-derived nutrients
WO2002066603A2 (en) 2001-02-15 2002-08-29 Centocor, Inc. Chemically defined medium for cultured mammalian cells
AU2002316230A1 (en) 2001-06-13 2002-12-23 Genentech, Inc. Methods of culturing animal cells and polypeptide production in animal cells
GB0208041D0 (en) * 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
US7261893B2 (en) 2002-10-22 2007-08-28 Wyeth Neutralizing antibodies against GDF-8 and uses therefor
GB0304799D0 (en) * 2003-03-03 2003-04-09 Glaxosmithkline Biolog Sa Novel method
US7871607B2 (en) 2003-03-05 2011-01-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
US20060104968A1 (en) 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
AU2004280065A1 (en) * 2003-10-09 2005-04-21 Kyowa Hakko Kirin Co., Ltd. Process for producing antibody composition by using RNA inhibiting the function of alpha1,6-fucosyltransferase
US7294484B2 (en) * 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
WO2006050050A2 (en) * 2004-10-29 2006-05-11 Centocor, Inc. Chemically defined media compositions
CN100569940C (zh) * 2006-08-16 2009-12-16 华东理工大学 人胚胎肾(hek)293细胞无血清培养基
EP2064314A4 (en) * 2006-09-13 2009-12-30 Abbott Lab IMPROVEMENTS TO CELL CULTURE
CL2007003583A1 (es) 2006-12-11 2008-07-18 Hoffmann La Roche Formulacion farmaceutica estable, parenteral, del anticuerpo contra el peptido beta amiloide (abeta); y uso de la formulacion para el tratamiento de la enfermedad de alzheimer.
US20100041146A1 (en) * 2007-01-12 2010-02-18 Nippon Sheet Glass Company, Limited Three-dimensional cell culture carrier and method for cell culture using the same
US8017390B2 (en) * 2007-07-20 2011-09-13 Dongguk University Industry-Academic Cooperation Foundation Method for the preparation of dermal papilla tissue employing mesenchymal stem cells
EP2197421A1 (en) * 2007-08-31 2010-06-23 Amgen, Inc Solid-state protein formulation
CN107090481A (zh) * 2008-04-17 2017-08-25 惠氏有限责任公司 提高骨形成蛋白产量的方法
KR20110060911A (ko) * 2008-09-26 2011-06-08 쉐링 코포레이션 고 역가 항체 생산
JO3672B1 (ar) * 2008-12-15 2020-08-27 Regeneron Pharma أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
US9540426B2 (en) * 2009-10-06 2017-01-10 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production
JP6347949B2 (ja) 2010-04-26 2018-06-27 ノバルティス アーゲー 改良型細胞培養培地

Also Published As

Publication number Publication date
JP2023156371A (ja) 2023-10-24
KR102339106B1 (ko) 2021-12-15
PL2841561T3 (pl) 2019-05-31
MX363493B (es) 2019-03-26
EP3533864A1 (en) 2019-09-04
CA2871006A1 (en) 2013-10-31
ZA201408092B (en) 2019-03-27
AU2019202259A1 (en) 2019-04-18
BR112014026308A8 (pt) 2021-06-01
RU2014147018A (ru) 2016-06-10
JP2021104023A (ja) 2021-07-26
HK1208496A1 (en) 2016-03-04
RU2678142C2 (ru) 2019-01-23
MY181513A (en) 2020-12-24
JP7323272B2 (ja) 2023-08-08
CA2871006C (en) 2021-05-25
MX2014012838A (es) 2015-10-22
BR112014026308A2 (pt) 2017-06-27
EP2841561B1 (en) 2019-01-16
KR20200057795A (ko) 2020-05-26
US20130281355A1 (en) 2013-10-24
AU2019202259B2 (en) 2021-11-11
CN111440758A (zh) 2020-07-24
EP2841561A1 (en) 2015-03-04
MX2019003427A (es) 2020-11-12
KR20150003351A (ko) 2015-01-08
SG11201406903SA (en) 2014-12-30
AU2013251647A1 (en) 2014-12-18
NZ701791A (en) 2017-03-31
IL235235A0 (en) 2014-12-31
RU2018146497A (ru) 2019-02-04
AU2013251647B2 (en) 2019-04-04
JP2015515281A (ja) 2015-05-28
US20240093143A1 (en) 2024-03-21
SG10201810830UA (en) 2018-12-28
JP2018183154A (ja) 2018-11-22
SI2841561T1 (sl) 2019-04-30
JP6367792B2 (ja) 2018-08-01
AR090822A1 (es) 2014-12-10
KR102115052B1 (ko) 2020-05-25
ES2716301T3 (es) 2019-06-11
WO2013163294A1 (en) 2013-10-31
ZA201707452B (en) 2021-03-31
CN104428409A (zh) 2015-03-18

Similar Documents

Publication Publication Date Title
HRP20190484T1 (hr) Pripravci stanične kulture i postupci proizvodnje polipeptida
IL288509A (en) Mammalian cell culture
IL273504A (en) Compositions for cell culture with antioxidants and methods for polypeptide production
HK1210494A1 (zh) 用於細胞培養的裝置和方法
IL236158A0 (en) Methods and compositions to create biomethane
EP2729561A4 (en) CELL CULTURE METHOD
SG11201504219QA (en) Recipient for cell cultivation
SG11201503579RA (en) Cell culture med
SG11201500417PA (en) Cell culture
EP2913392A4 (en) RECOMBINANT CELL AND METHOD FOR THE PRODUCTION OF ISOPRENE
GB201200458D0 (en) Methods of preparing cells and compositions
GB2504996A8 (en) Stem cell culture method
SG11201406622UA (en) An in vitro method for culturing stem cells
GB201211873D0 (en) Cell culture
HK1210436A1 (en) Novel cell compositions and methods